How MEDVi Grew to $401 Million and What Its Rise Reveals About Telehealth
There are companies that grow, companies that grow fast, and companies whose growth tells you something fundamental has changed in the market around them.
MEDVi belongs in the third category.
The telehealth company launched in September 2024. According to reporting based on financial records reviewed by The New York Times, MEDVi generated approximately $401 million in 2025 sales from 250,000 customers, producing roughly $65 million in net profit, or a 16.2% net margin. The same reporting said the company was tracking toward $1.8 billion in 2026 annual sales.
Those numbers would be remarkable for almost any startup. They are even more remarkable because MEDVi was built around an unusually lean operating model. Founder Matthew Gallagher reportedly used more than a dozen AI tools, outsourced major pieces of clinical and fulfillment infrastructure, and kept the internal team extremely small.
That is why the MEDVi story should not be reduced to an AI novelty story.
MEDVi is a telehealth market-structure story.
It shows what can happen when consumer demand, telehealth infrastructure, direct-response marketing, GLP-1 awareness, outsourced operations, affiliate distribution and AI-assisted execution collide at the same moment.
MEDVi did not invent telemedicine. It did not create GLP-1 demand. It did not create online prescription fulfillment. It did not invent performance marketing, affiliate marketing or AI.
What it did was assemble those pieces at precisely the moment consumers had become far more comfortable buying healthcare through digital channels.
That makes MEDVi worth studying, not because every healthcare founder should copy the company, but because its rise provides an unusually clear look at the forces reshaping direct-to-consumer healthcare.
MEDVi Did Not Create Telehealth. It Showed How Consumerized Telehealth Had Become.
Telehealth existed long before MEDVi.
The COVID-19 pandemic accelerated adoption at a scale that would have taken much longer under normal conditions. McKinsey reported that telehealth utilization in early 2021 was dramatically above pre-pandemic levels, and federal data shows that virtual care remained a meaningful part of healthcare after the emergency phase passed.
The U.S. Department of Health and Human Services reports that 25% of Medicare fee-for-service users received a telehealth service in 2024. HHS also reports widespread telehealth use among federally funded health centers.
That matters because the behavioral barrier has changed.
Millions of Americans now understand the basic proposition:
- start on a phone or computer
- complete intake digitally
- communicate with a licensed provider remotely when appropriate
- receive a prescription when clinically appropriate
- have medication or services delivered
- manage follow-up digitally
Once consumers learn that some healthcare can be delivered this way, traditional healthcare is no longer competing only with other healthcare organizations.
It is also competing with every frictionless digital experience consumers use elsewhere.
Amazon teaches consumers to expect easy ordering. Banking apps teach them to expect account access at any hour. DoorDash teaches them to expect location, status and delivery visibility. Ecommerce teaches them to expect clear pricing and a short checkout.
Healthcare cannot permanently remain exempt from those expectations.
That is the environment MEDVi entered.
Then GLP-1s Changed the Economics
Telehealth created the distribution architecture. GLP-1 demand supplied an extraordinary catalyst.
Semaglutide and tirzepatide became household names. Consumer awareness exploded. Search volume expanded. News coverage became constant. Weight management moved from a category dominated by diet programs, gyms and in-person care into a market where consumers increasingly knew there were physician-guided pharmaceutical options.
This created a powerful acquisition environment for direct-to-consumer telehealth.
You had a painful and emotionally important problem, enormous category awareness, active search behavior, recurring treatment potential and a growing consumer willingness to use virtual care.
That combination is direct-response rocket fuel.
MEDVi entered where demand already existed.
Lesson 1: Stop Trying to Manufacture Demand
One of the most common mistakes founders make is falling in love with a market because they personally find it interesting.
That does not mean consumers care.
MEDVi entered a category where demand was already obvious. Hims & Hers was there. Ro was there. Venture-backed telehealth brands were there. Physicians were prescribing GLP-1 medications. Pharmacies and manufacturers were already in the ecosystem.
MEDVi entered anyway.
That is an important growth lesson.
You do not necessarily need an empty market. You need a market large enough, painful enough and active enough that you can acquire customers profitably.
Competition often proves money is changing hands.
The strategic questions are simple:
- What are people already searching for?
- What are they already buying?
- Where are they frustrated?
- Which problems are important enough to trigger action?
- Where are buyers already spending money?
Existing demand is one of the greatest gifts a marketer can receive.
MEDVi positioned itself directly in the path of it.
The Second MEDVi Insight: You Do Not Have to Own the Entire Healthcare Stack
This may be the most important part of the case study.
Traditional thinking says that building a major healthcare company requires enormous proprietary infrastructure. You need clinicians, pharmacies, fulfillment, prescription workflows, compliance operations, customer service, engineering, patient software, billing, analytics and logistics.
MEDVi approached the problem differently.
Reporting by Forbes and others describes a deliberately thin architecture in which outside platforms such as CareValidate and OpenLoop Health supplied significant parts of the licensed provider, prescription, pharmacy, fulfillment and operational infrastructure. MEDVi focused heavily on the customer relationship, marketing, software layer and acquisition experience.
That distinction is enormous.
It resembles what Shopify did to ecommerce. A brand no longer has to invent payment processing, build a cart from scratch, write warehouse software and create every technical component before selling its first product.
Increasingly, telehealth companies can assemble infrastructure rather than invent every layer.
Provider networks can be partners. Pharmacy fulfillment can be partners. Lab systems can integrate. Patient communication platforms can integrate. Identity tools can integrate. CRM systems can be purchased. Payment infrastructure can be purchased. AI can connect workflows that previously required more engineering and labor.
That does not eliminate clinical responsibility, privacy obligations or compliance requirements.
It changes the capital required to enter the market.
Telehealth Is Becoming an Infrastructure Layer
This is where the MEDVi story becomes much bigger than MEDVi.
Telehealth should no longer be thought of only as a category of companies.
It is increasingly becoming an infrastructure layer.
A consumer brand can sit on top of provider networks, pharmacies, software, lab integrations, communications tools, payment systems and logistics partners.
That creates specialization.
One company becomes exceptional at patient acquisition. Another becomes exceptional at provider infrastructure. Another specializes in pharmacy fulfillment. Another handles patient communication. Another provides diagnostics. Another provides payment or revenue-cycle infrastructure.
Software and APIs connect the system.
We have seen this modularization in ecommerce, fintech and cloud software. When infrastructure becomes modular, the cost of experimentation falls and the speed of company creation rises.
Lesson 2: Own the Differentiator, Rent the Commodity
There are parts of healthcare that should never be treated casually. Clinical quality, patient safety, privacy and compliance are not commodities.
But founders should still ask a hard strategic question:
What do we actually need to own?
Do you need proprietary scheduling software on day one? Probably not.
Do you need to own a pharmacy before you validate the offer? Not necessarily.
Do you need a giant internal engineering team before testing acquisition? Maybe not.
Every dollar spent recreating mature infrastructure is a dollar not spent on differentiation.
The MEDVi model suggests that a telehealth brand can keep far more of its organizational energy pointed toward demand generation, customer experience, automation and product iteration when it uses external infrastructure intelligently.
The AI Story Is Really a Leverage Story
MEDVi's founder reportedly used tools including ChatGPT, Claude, Grok, Midjourney, Runway and other AI systems for software development, copy, creative, customer service, analysis and workflow automation.
The useful lesson is not "replace everyone with AI."
The useful lesson is that the minimum viable organization has become dramatically smaller.
A capable operator can now perform work that previously required multiple departments:
- coding
- copywriting
- creative production
- analysis
- research
- workflow automation
- reporting
- customer-support triage
- documentation
- testing
The marginal cost of experimentation has fallen.
And in direct response, testing velocity matters.
Lesson 3: AI Does Not Just Reduce Payroll. It Increases Speed.
Imagine Company A needs a copywriter, designer, developer, project manager, compliance reviewer, marketing manager and analyst for every meaningful landing-page test.
Now imagine Company B where a small team can use AI to generate hypotheses, draft copy, create wireframes, build first-pass code, analyze results and propose the next test.
Company B may complete ten learning cycles while Company A is scheduling its second meeting.
That is not just a payroll advantage.
It is a learning advantage.
The company that runs more intelligent experiments can learn faster. The company that learns faster can compound small advantages into a meaningful competitive edge.
Speed is not the same thing as recklessness. Healthcare still requires clinical and compliance controls. But slow organizations should not confuse bureaucracy with safety.
MEDVi Understood the Difference Between Healthcare Marketing and Healthcare Delivery
The patient sees one brand.
Behind that brand may be an entire ecosystem of vendors, clinicians, pharmacies, technology and logistics partners.
This matters because consumers rarely buy infrastructure.
They buy outcomes and experiences.
They do not care which cloud provider hosts a streaming service. They care whether the video plays.
They do not care which processor moved the card payment. They care whether checkout worked.
Telehealth patients generally begin with questions such as:
- Can you help me?
- How much does it cost?
- Can I qualify?
- Is a licensed medical provider involved?
- How quickly can I start?
- What happens next?
The brands that answer those questions most clearly have a major advantage.
Lesson 4: Reduce the Number of Decisions Between Desire and Action
This is fundamental direct response.
Every additional decision creates friction.
Every unnecessary field creates friction.
Every confusing price creates friction.
Every unanswered objection creates friction.
Traditional healthcare tolerated enormous friction because consumers had few alternatives.
Call the office. Wait on hold. Schedule an appointment. Drive there. Complete paperwork. Sit in the waiting room. Drive somewhere else. Go to a pharmacy. Wait again.
Telehealth changes the reference point.
Now the consumer asks a simple question:
Why can I not do this online?
That question will keep spreading into every category where remote delivery is clinically appropriate.
Lesson 5: Clarity Beats Cleverness
Healthcare websites have a bad habit of writing like committees.
"Reimagining integrated personalized wellness through innovative patient-centric solutions" may sound impressive internally, but it tells the customer almost nothing.
A good telehealth homepage should answer in seconds:
- Who is this for?
- What problem do you solve?
- What can I get?
- How does it work?
- Why should I trust you?
- What does it cost?
- What should I do next?
If a visitor needs several minutes to understand the offer, conversion suffers.
Marketing is not an art contest.
Its job is to move people from confusion to understanding and, when appropriate, from understanding to action.
Affiliate Marketing Added Fuel
Business Insider reported that affiliates represented a meaningful portion of MEDVi's advertising activity.
That makes sense strategically.
Affiliate marketing converts parts of fixed marketing overhead into performance-based distribution.
Instead of one internal media-buying team testing every angle, outside publishers can test creative, placements, advertorials, search campaigns, social campaigns, email and other formats.
Suddenly the business does not have one marketing laboratory.
It may have hundreds.
That can create tremendous scale.
It can also create tremendous risk.
The Part Telehealth Founders Should Not Copy
Healthcare advertising is not an ordinary ecommerce environment.
In February 2026, the FDA issued a warning letter to MEDVi, LLC dba MEDVi after reviewing website content at medvi.io. The agency said it found false or misleading claims concerning compounded semaglutide and tirzepatide products and cited misbranding concerns under the Federal Food, Drug, and Cosmetic Act.
Business Insider also reported on affiliate advertising connected to MEDVi that appeared to use questionable or AI-generated medical personas and raised questions about disclosure and oversight.
The right conclusion is not that aggressive growth is bad.
The right conclusion is that distribution systems require governance systems.
When you outsource customer acquisition, you do not outsource reputational risk.
Lesson 6: Affiliate Scale Requires Affiliate Governance
Affiliate programs can generate tremendous growth, but healthcare companies need the ability to answer:
- Who is advertising?
- Which domains are being used?
- Which advertorials are live?
- Which claims appear on those pages?
- Which videos are running?
- Are testimonials authentic?
- Are material relationships disclosed?
- Are compounded products described accurately?
- Are FDA-approved and compounded products clearly distinguished?
- Can unauthorized creative be shut down quickly?
- Who archives creative?
- Who monitors affiliates?
- Who owns escalation?
AI makes this more urgent because creative production is now nearly unlimited.
Ten years ago, producing 500 video variations was expensive.
Today, hundreds of variations can be generated very quickly.
Compliance systems have to scale at the same pace as creative systems.
Regulation Is Not the Enemy of Growth
Some marketers treat compliance as though its purpose is to prevent marketing.
That is shortsighted.
Good compliance protects enterprise value.
If you build a healthcare company worth hundreds of millions of dollars, the cost of reckless advertising increases dramatically.
The FTC has already taken enforcement action against other telehealth companies over issues including misleading pricing, unsupported claims, fake reviews and billing practices.
The next generation of elite telehealth marketers will not simply know how to scale.
They will know how to scale inside regulatory boundaries.
That is a competitive advantage.
What MEDVi Reveals About the Consumerization of Healthcare
Zoom out from GLP-1s.
This is where the story becomes much bigger.
MEDVi has expanded beyond its original weight-management offer into additional health categories. That is what I would expect from the economics of a digitally acquired healthcare relationship.
Once a telehealth company acquires a patient, establishes trust and builds infrastructure for ongoing digital care, the first product may become the door rather than the entire business.
A consumer may enter for weight management and later need services related to:
- men's health
- women's health
- hormonal care
- hair loss
- metabolic health
- nutrition
- diagnostics
- primary care
- longitudinal support
Now the company is no longer competing for one transaction.
It is competing for a healthcare relationship.
That is a much bigger prize.
Lesson 7: The First Product May Simply Be the Door
Customer acquisition can be expensive.
If a company has to recover 100% of acquisition cost from the first transaction, growth becomes difficult.
But if a patient relationship can continue for years across clinically appropriate services, the economics change.
Lifetime value can include recurring care, memberships, follow-up, additional care categories, diagnostics and other services that fit the patient's needs.
The company with the strongest lifetime-value economics can often afford to spend more to acquire a customer.
And the company that can afford to spend more frequently wins the advertising auction.
Distribution Can Be More Valuable Than Product Innovation
This idea bothers product people, but it has always been true.
The best product does not automatically win.
The company capable of getting an appropriate product in front of the largest number of qualified customers has a major advantage.
MEDVi did not invent semaglutide. It did not invent tirzepatide. It did not invent telehealth visits, compounding pharmacies or physician networks.
Its breakthrough was largely architectural and commercial.
Bring the pieces together. Wrap them in a consumer proposition. Remove friction. Acquire customers. Automate aggressively. Move quickly. Scale what works.
That model will be copied in categories far beyond weight management.
Where the Next Telehealth Growth Categories May Emerge
Obvious categories already include:
- women's health
- menopause
- men's health
- sexual health
- hair loss
- dermatology
- mental health
- sleep
- metabolic health
- longevity
- fertility
- chronic-condition management
- diagnostics
- preventive care
Some are better suited to telehealth than others.
Healthcare will not become entirely virtual. Many conditions require physical examination, procedures, testing or in-person intervention.
The winning thesis is not "everything becomes telehealth."
It is this:
Everything that can safely and effectively move online will face increasing pressure to do so.
Lesson 8: Start Narrow Enough to Become Relevant
Broad vision sounds impressive in a pitch deck.
Specific problems generate customers.
Compare these two messages:
Company A: Personalized virtual health solutions for a better tomorrow.
Company B: See if you qualify for doctor-guided online weight-management treatment.
The second is easier to understand because specificity creates relevance.
Many successful telehealth brands began with narrow categories before expanding.
That is strategically rational.
Dominate a wedge, then move outward.
The Hidden Growth Engine: Removing Embarrassment
Some healthcare conditions come with emotional friction.
Sexual-health issues. Weight. Hair loss. Mental health. Hormonal symptoms. Certain dermatological conditions.
People may delay care because they do not want to sit in a waiting room or discuss the issue face to face before they are ready.
Telehealth can reduce some of that friction.
A patient can begin privately, from home, on a phone.
That is not merely convenience.
It may change whether someone seeks care at all.
The Smartphone Is Becoming a Front Door to Healthcare
For decades, the front door to healthcare was a physical building.
You called an office, drove there and checked in.
For more healthcare journeys, the first interaction now happens through Google, Meta, YouTube, TikTok, an app, an email or a website.
That means something important for healthcare executives:
Marketing is increasingly part of healthcare infrastructure.
Not because marketers practice medicine. They do not.
Marketing influences how patients discover care, how options are explained, how much they understand pricing, how they complete intake, how they schedule, how they stay engaged and whether they return.
Healthcare executives who do not understand consumer acquisition will increasingly compete against companies that do.
What Traditional Healthcare Can Learn From MEDVi
A hospital system should not copy MEDVi's ads.
That is not the lesson.
The deeper questions are:
- Why does scheduling still require a phone call?
- Why are prices so hard to understand?
- Why does the patient repeatedly provide the same information?
- Why is follow-up not automated?
- Why are communications fragmented?
- Why can appropriate visits not happen online?
- Why can the patient not easily see what happens next?
Healthcare does not need disruption for disruption's sake.
It needs unnecessary friction removed.
The $401 Million Question
How does a company founded in September 2024 reportedly produce $401 million in sales during 2025?
There is no single answer.
It is the combination:
- a massive problem
- exploding category demand
- consumer awareness
- telehealth adoption
- outsourced clinical infrastructure
- pharmacy infrastructure
- digital acquisition
- affiliate distribution
- AI automation
- fast testing
- clear offers
- simple enrollment
- recurring economics
- high lifetime-value potential
- timing
Remove several of those ingredients and MEDVi probably is not MEDVi.
That is why copying its landing page will not reproduce the result.
The landing page is not the strategy. The system is the strategy.
What I Would Copy From MEDVi
1. Enter Existing Demand
I would rather take a meaningful share of a massive, growing category than own 100% of something nobody wants.
2. Use Infrastructure Before Building Infrastructure
Validate the market before spending millions recreating capabilities partners already provide.
3. Obsess Over Speed
The company learning fastest has a major advantage.
4. Build Conversion Into the Product Experience
Intake, scheduling, checkout, reminders and follow-up are not merely operations. They are conversion systems.
5. Make the Offer Painfully Clear
Tell consumers what they get, how it works and what happens next.
6. Use AI to Increase Organizational Leverage
Not because AI is fashionable, but because capable teams can now execute dramatically more work.
7. Create Multiple Acquisition Channels
Paid social, search, affiliates, organic content, email, partnerships and referral all matter. A major company should not permanently depend on one advertising account.
8. Think Beyond the First Transaction
Lifetime value determines how aggressively you can grow.
9. Build Compliance Into the Marketing Architecture
Do not bolt it on after scale.
10. Own the Customer Relationship
Infrastructure can be outsourced. Trust cannot.
What I Would Not Copy
I would not allow uncontrolled affiliates to make medical claims.
I would not use testimonials whose authenticity I could not document.
I would not create confusion between compounded and FDA-approved medications.
I would not imply physician endorsements that do not exist.
I would not use AI-generated medical authority figures in a way that could mislead consumers.
I would not allow AI customer-service systems to invent prices, products or medical information.
I would not sacrifice compliance to improve conversion rate.
Healthcare marketing is not selling an ordinary consumer product.
The consequences are different. The responsibility is different.
The Bigger AI Lesson
The headline everyone remembers is the tiny headcount.
The longer-term story is more important.
Artificial intelligence lowers the minimum size required to operate a sophisticated company.
That means more entrepreneurs can enter telehealth. A founder no longer necessarily needs a huge technology department before testing an idea.
They may be able to connect a clinical network, pharmacy, CRM, payment platform, patient portal, automation, customer support, analytics and advertising using existing infrastructure and a relatively small team.
This will create more competition.
And that means the basic ability to launch becomes less valuable.
The differentiators move elsewhere:
- brand
- trust
- distribution
- clinical quality
- retention
- patient experience
- economics
- compliance
- intellectual property
- audience
Those become the moat.
Building the Company Will Get Easier. Building the Brand Will Get Harder.
This pattern occurs whenever technology becomes easier.
When building a website required a developer, simply having a website created an advantage.
Now everyone has one.
When professional video required a studio, video production itself was differentiated.
Now AI can generate video.
When ecommerce required custom infrastructure, ecommerce technology was the moat.
Shopify changed that.
Telehealth may follow the same path.
As infrastructure becomes available to everyone, launching gets easier. More competitors appear.
Then the question is no longer "Can you build it?"
The question becomes "Can you make anyone care?"
That is marketing.
Why Search Matters Even More in High-Awareness Telehealth Categories
When consumers already know what they want, search is extremely powerful.
A person searching for "semaglutide telehealth," "tirzepatide online" or "online weight loss doctor" is different from someone casually scrolling social media.
Search captures intent.
Social creates, redirects or amplifies attention.
Both matter, but marketers should understand the customer's awareness level.
MEDVi benefited from a category where millions of consumers already knew the product class existed.
That made direct-response acquisition dramatically easier than launching an unknown solution to an unknown problem.
The Real Opportunity Is Not Telehealth
Here is the contrarian part.
The opportunity is not telehealth.
Telehealth is a delivery mechanism.
The opportunity is healthcare demand that traditional systems serve poorly.
That is where I would look.
- Where are people waiting weeks?
- Where are consumers embarrassed?
- Where are prices opaque?
- Where is the patient journey fragmented?
- Where are treatments recurring?
- Where can meaningful portions of care safely occur remotely?
- Where are patients already spending money?
- Where is consumer awareness rising?
- Where does the existing system irritate everyone who interacts with it?
Those are the markets worth studying.
The technology comes second.
The Market Has Already Voted on Telehealth
You can debate whether individual telehealth valuations are justified.
You can debate compounded GLP-1 policy.
You can debate whether MEDVi's specific model proves durable.
You can debate AI.
Those are legitimate questions.
But the broad consumer behavior is no longer hypothetical.
Millions of Americans use virtual care, and MEDVi's reported growth shows how quickly a focused consumer telehealth brand can scale when the market conditions align.
That does not tell us every part of the model is perfect.
It tells us consumers are willing to obtain healthcare differently.
That is the signal.
The Future Probably Is Not Called Telehealth
Eventually, we may stop treating telehealth as a separate category.
Nobody under 30 describes paying a bill in a banking app as "digital banking."
They are simply banking.
Healthcare may evolve the same way.
Some visits happen physically. Others happen by video. Some communication is asynchronous. Some diagnostics happen at home. Prescriptions move electronically. Medication arrives by mail. Wearables supply data. AI assists with administrative workflows. Medical professionals remain responsible for clinical judgment.
The patient does not think of these as separate industries.
It is just healthcare.
MEDVi's growth may ultimately be remembered as one of many signals that this transition was accelerating.
What Telehealth Founders Should Learn From MEDVi
MEDVi should not be treated as a perfect company to copy.
The FDA warning letter and affiliate-advertising questions are material parts of the story.
But dismissing the entire company because of those issues would be just as foolish as blindly copying everything it did.
Study the system.
It entered a market with extraordinary demand. It used partners instead of recreating every layer. It moved fast. It used AI to increase organizational leverage. It built around direct-to-consumer acquisition. It made the consumer proposition easy to understand. It treated healthcare as a customer experience. It found distribution. It expanded outward from one high-demand category.
Then study the other side.
Affiliate oversight matters. Medical claims matter. Advertising substantiation matters. AI can accelerate mistakes just as fast as it accelerates useful work. Compliance has to scale alongside marketing.
Those are not footnotes.
They are part of the case study.
The Companies That Win the Next Phase of Telehealth
The first wave of telehealth proved consumers would interact with clinicians remotely.
The next wave proved specialized virtual clinics could become significant businesses.
Now we are entering another phase.
The infrastructure is maturing. Consumers are comfortable. Pharmacy logistics are increasingly connected. Provider networks can be accessed through platforms. AI increases operational leverage. Direct-response acquisition can produce extraordinary scale.
The result is something fundamentally different from the first generation of telemedicine.
Healthcare brands can be assembled, tested and scaled at speeds that would have seemed absurd a decade ago.
MEDVi may be one of the clearest examples yet.
It will not be the last.
The Bottom Line
MEDVi did not create the telehealth revolution.
The pandemic accelerated adoption years earlier. GLP-1s did not create telemedicine. AI did not create it either.
MEDVi arrived at the intersection of three powerful forces:
consumer acceptance of virtual healthcare
massive demand for a highly sought-after treatment category
technology and outsourced infrastructure that let a remarkably small organization operate at enormous scale
That is why MEDVi matters.
Its story is not proof that every entrepreneur can spend $20,000 and build a billion-dollar telehealth company.
That would be fantasy.
It is evidence that some assumptions about what it takes to build a large healthcare business are becoming obsolete.
The cost of building has fallen. The speed of experimentation has increased. Infrastructure can increasingly be assembled rather than invented. Distribution remains king. Consumers have demonstrated that when healthcare is appropriate for virtual delivery, they are increasingly willing to receive it that way.
The big question is no longer whether telehealth is real.
The market answered that years ago.
The question now is:
Who will build the brands that own the next phase of it?
Sources and Further Reading
- The New York Times report republished by GV Wire: A $1.8 Billion Company With Two Employees? AI Made It Possible
- Forbes: How a Telehealth Startup Found Success With Just $20,000 and AI
- Business Insider: MEDVi affiliate advertising and compliance investigation
- FDA Warning Letter to MEDVi, LLC dba MEDVi, February 20, 2026
- U.S. HHS Telehealth Research and Trends
- McKinsey: From Facility to Home
- FTC telehealth enforcement example: NextMed
For the broader software architecture behind virtual care, see Best Telehealth Software Platforms: 2026 Buyer’s Guide and Telehealth Tech Stack & Vendor Compliance.
